Pomerantz Pursues Securities Action Against Varonis Following Earnings Miss

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Pomerantz Law Firm files class action lawsuit against Varonis Systems for securities fraud following a 63.9% revenue decline and 48.67% stock drop.

Pomerantz Pursues Securities Action Against Varonis Following Earnings Miss

Pomerantz Law Firm has initiated a class action lawsuit against Varonis Systems, Inc., alleging securities fraud and unlawful business practices stemming from the company's October 28, 2025 earnings announcement. The disclosure revealed a significant 63.9% decline in term license subscription revenues, prompting management to reduce full-year annual recurring revenue (ARR) guidance due to underperformance in the on-premises subscription segment. The market reaction was severe, with Varonis shares declining 48.67% in the days following the announcement.

The lawsuit represents efforts by investors who sustained losses during this period to pursue claims against the company and its leadership. The material revenue shortfall and subsequent guidance reduction raise questions about the accuracy of prior financial projections and management's disclosure practices regarding business performance trends. Investors who purchased or held Varonis securities during the relevant period and experienced losses are being notified of the litigation opportunity.

Investors seeking to participate in the class action as Lead Plaintiff must meet the March 9, 2026 deadline. Participation in the lawsuit allows shareholders to potentially recover losses without bearing individual litigation costs, as the case proceeds on a class-wide basis against the company.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 24

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP